Thomas P. Slavin

1.8k total citations · 1 hit paper
17 papers, 338 citations indexed

About

Thomas P. Slavin is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Thomas P. Slavin has authored 17 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Thomas P. Slavin's work include BRCA gene mutations in cancer (13 papers), Cancer Genomics and Diagnostics (5 papers) and Genetic factors in colorectal cancer (3 papers). Thomas P. Slavin is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Cancer Genomics and Diagnostics (5 papers) and Genetic factors in colorectal cancer (3 papers). Thomas P. Slavin collaborates with scholars based in United States, Canada and Mexico. Thomas P. Slavin's co-authors include Jeffrey N. Weitzel, Ilana Solomon, Christina Rybak, Mariana Niell‐Swiller, Bita Nehoray, Kathleen R. Blazer, Allison W. Kurian, Rachel Hodan, Katherine L. Nathanson and Lily Hoang and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Thomas P. Slavin

17 papers receiving 335 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline Genetic Testing After Cancer Diagnosis

2023 66 citations Allison W. Kurian, Paul Abrahamse et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas P. Slavin United States	7	223	113	104	90	65	17	338
Danielle Castillo United States	9	222 1.0×	130 1.2×	103 1.0×	60 0.7×	81 1.2×	27	327
Jana Soukupová Czechia	12	200 0.9×	210 1.9×	112 1.1×	104 1.2×	110 1.7×	38	467
Carlos J. Gallego United States	6	127 0.6×	63 0.6×	76 0.7×	100 1.1×	55 0.8×	10	261
Joe Dennis United Kingdom	9	109 0.5×	88 0.8×	61 0.6×	39 0.4×	78 1.2×	24	247
John L. Hopper Australia	4	180 0.8×	73 0.6×	62 0.6×	53 0.6×	129 2.0×	5	308
Judy-Anne W. Chapman Canada	8	138 0.6×	85 0.8×	124 1.2×	68 0.8×	185 2.8×	9	358
Maurício Magalhães Costa Brazil	10	177 0.8×	168 1.5×	135 1.3×	43 0.5×	114 1.8×	19	336
Isabella Marchi Italy	11	188 0.8×	90 0.8×	88 0.8×	46 0.5×	119 1.8×	17	269
Molly Sebastian United States	4	169 0.8×	54 0.5×	134 1.3×	78 0.9×	76 1.2×	9	263
Kalotina Machini United States	9	370 1.7×	109 1.0×	111 1.1×	74 0.8×	27 0.4×	15	518

Countries citing papers authored by Thomas P. Slavin

Since Specialization

Citations

This map shows the geographic impact of Thomas P. Slavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Slavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Slavin more than expected).

Fields of papers citing papers by Thomas P. Slavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Slavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Slavin. The network helps show where Thomas P. Slavin may publish in the future.

Co-authorship network of co-authors of Thomas P. Slavin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Slavin. A scholar is included among the top collaborators of Thomas P. Slavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Slavin. Thomas P. Slavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Iliev, Diana, Chelsea R. Kasten, Howard Korman, et al.. (2024). Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing. Prostate Cancer and Prostatic Diseases. 28(2). 427–434. 2 indexed citations

Daly, Mary B., Eric T. Rosenthal, Shelly Cummings, et al.. (2023). The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast Cancer Research and Treatment. 199(3). 617–626. 5 indexed citations

Kurian, Allison W., Paul Abrahamse, Allison Furgal, et al.. (2023). Germline Genetic Testing After Cancer Diagnosis. JAMA. 330(1). 43–43. 66 indexed citations breakdown →

Jones, Melanie A., Kirsten M. Timms, Elizabeth S. Cogan, et al.. (2023). The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next‐generation sequencing. Genes Chromosomes and Cancer. 62(10). 589–596. 3 indexed citations

Shore, Neal D., Elizabeth S. Cogan, Diana Iliev, et al.. (2022). Hereditary cancer risk assessment and genetic testing in the community urology practice setting. The Prostate. 82(7). 850–857. 2 indexed citations

Weitzel, Jeffrey N., John Kidd, Ryan Bernhisel, et al.. (2021). Multigene assessment of genetic risk for women for two or more breast cancers. Breast Cancer Research and Treatment. 188(3). 759–768. 5 indexed citations

Reckamp, Karen L., Carolyn E. Behrendt, Thomas P. Slavin, et al.. (2021). Germline mutations and age at onset of lung adenocarcinoma. Cancer. 127(15). 2801–2806. 18 indexed citations

Kurian, Allison W., Elisha Hughes, Timothy Simmons, et al.. (2021). Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative. Cancer. 127(20). 3742–3750. 27 indexed citations

Chávarri-Guerra, Yanin, et al.. (2020). Genetic cancer predisposition syndromes among older adults. Journal of Geriatric Oncology. 11(7). 1054–1060. 3 indexed citations

10.

Weitzel, Jeffrey N., Kathleen R. Blazer, Thomas P. Slavin, et al.. (2019). Germline mutation profile among Hispanic women with epithelial ovarian cancer (EOC).. Journal of Clinical Oncology. 37(15_suppl). 1584–1584. 1 indexed citations

11.

Offit, Kenneth, Kasmintan A. Schrader, Kara N. Maxwell, et al.. (2016). Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing.. Journal of Clinical Oncology. 34(15_suppl). 1515–1515. 1 indexed citations

12.

Hart, Steven N., Joseph Vijai, Kasmintan A. Schrader, et al.. (2016). Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. The American Journal of Human Genetics. 98(5). 801–817. 81 indexed citations

13.

Slavin, Thomas P., Mariana Niell‐Swiller, Ilana Solomon, et al.. (2015). Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management. Frontiers in Oncology. 5. 208–208. 75 indexed citations

14.

Weitzel, Jeffrey N., Kathleen R. Blazer, Bita Nehoray, et al.. (2015). Assessment of the clinical presentation of patients with at least two deleterious mutations on multi-gene panel testing.. Journal of Clinical Oncology. 33(15_suppl). 1514–1514. 3 indexed citations

15.

Slavin, Thomas P., et al.. (2014). Elevated blood pressure: Our family’s fault? The genetics of essential hypertension. World Journal of Cardiology. 6(5). 327–327. 21 indexed citations

16.

Mochizuki, Aaron, James Hyland, Timothy L. Brown, & Thomas P. Slavin. (2014). Is Tel Hashomer camptodactyly a distinct clinical entity?. American Journal of Medical Genetics Part A. 167(1). 255–258. 2 indexed citations

17.

Slavin, Thomas P., Noam Lazebnik, Dinah Clark, et al.. (2012). Germline mosaicism in Cornelia de Lange syndrome. American Journal of Medical Genetics Part A. 158A(6). 1481–1485. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact